A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 × 106/l

Susan L. Koletar*, Alison E. Heald, Dianne Finkelstein, Richard Hafner, Judith S. Currier, J. Allen McCutchan, Marc Vallee, Francesca J. Torriani, William G. Powderly, Robert J. Fass, Robert L. Murphy

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 × 106/l'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science